The Synth Sense
Geoffrey Potjewyd | | Quick Read
Interesting trend alert. Enter the alteration of low THC cannabis to include synthetic cannabinoid receptor agonists – effectively increasing activation of cannabinoid receptors, carrying risks for those who use the modified cannabis.
In response to this, the Trans European Drug Information (TEDI) network have tracked a highly potent and most common form of this modification, MDMB-4en-PINACA, across Europe – finding that, since April 2020, nine different drug checking services across eight countries identified this synthetic adulteration in low THC cannabis (1).
From the 1,142 cannabis samples tested – in e-liquid, herbal, or resin form – a shocking 270 contained MDMB-4en-PINACA, resulting in three reports of hospitalization. As it stands, cannabis users aren’t a usual group that would be targeted for drug checking services, but, in light of this research, maybe that needs to change.